Literature DB >> 16044211

Differential effect of Huntington's and Parkinson's diseases in programming motor sequences of varied lengths.

L Yágüez1, H W Lange, V Hömberg.   

Abstract

BACKGROUND: Parkinson's disease (PD) and Huntington's disease (HD) patients have difficulties executing sequential movements. Attention control and short-term memory probably play an important role in programming sequential movements. To investigate the contribution of these cognitive factors to programming and executing visuomotor sequences in HD and PD patients a computerized version of the Corsi Block Tapping-Test was employed.
METHODS: the performance of 11 patients with early stage PD, 11 HD patients with borderline to mild caudate atrophy and 20 healthy subjects was compared. The task was a reaction time task where targets were illuminated in groups of sequences increasing from 2 items to 5 items. Subjects reproduced the sequence (pressing the illuminated target) in the same order of appearance. Reaction Times and movement times were recorded.
RESULTS: PD patients had increasing difficulties in programming and executing series greater than three components. HD patients did not differ significantly from the controls, although they showed a tendency to lose accuracy in the longer series. Both patient groups did not differ in their attention span.
CONCLUSIONS: In PD although the spatial information may be well stored, they have difficulty accessing it when their attention is overloaded, leading to poor encoding and slow information processing. This process interferes with programming and execution of movement sequences. HD patients in the early stages of the illness seem to have more attention resources than PD patients, so that they start to show more problems in executing visuomotor sequences with longer movement sequences than PD patients.

Entities:  

Mesh:

Year:  2005        PMID: 16044211     DOI: 10.1007/s00415-005-0951-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Increased blood flow in the basal ganglia when using cues to direct attention.

Authors:  L Koski; T Paus; N Hofle; M Petrides
Journal:  Exp Brain Res       Date:  1999-11       Impact factor: 1.972

Review 2.  Relationships among processing speed, working memory, and fluid intelligence in children.

Authors:  A F Fry; S Hale
Journal:  Biol Psychol       Date:  2000-10       Impact factor: 3.251

Review 3.  Frontal-striatal circuit functions: context, sequence, and consequence.

Authors:  Jean A Saint-Cyr
Journal:  J Int Neuropsychol Soc       Date:  2003-01       Impact factor: 2.892

4.  Encapsulated cell implantation for Parkinson's disease.

Authors:  L Christenson; D F Emerich; P R Sanberg
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

5.  Motor strategies involved in the performance of sequential movements.

Authors:  R Benecke; J C Rothwell; B L Day; J P Dick; C D Marsden
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Simple and complex movements off and on treatment in patients with Parkinson's disease.

Authors:  R Benecke; J C Rothwell; J P Dick; B L Day; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

7.  Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease.

Authors:  E S Garnett; G Firnau; C Nahmias; R Carbotte; G Bartolucci
Journal:  J Neurol Sci       Date:  1984-08       Impact factor: 3.181

8.  Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  B Pillon; B Deweer; Y Agid; B Dubois
Journal:  Arch Neurol       Date:  1993-04

9.  Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

Authors:  E D Playford; I H Jenkins; R E Passingham; J Nutt; R S Frackowiak; D J Brooks
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

10.  Impairment of rapid movement in Huntington's disease.

Authors:  H Hefter; V Hömberg; H W Lange; H J Freund
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

View more
  7 in total

Review 1.  "Pre-symptomatic" Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Handb Clin Neurol       Date:  2008

2.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

3.  Raclopride-induced motor consolidation impairment in primates: role of the dopamine type-2 receptor in movement chunking into integrated sequences.

Authors:  M Levesque; M A Bedard; R Courtemanche; P L Tremblay; P Scherzer; P J Blanchet
Journal:  Exp Brain Res       Date:  2007-07-26       Impact factor: 1.972

4.  Diminished activation of motor working-memory networks in Parkinson's disease.

Authors:  Claudia Rottschy; Alexandra Kleiman; Imis Dogan; Robert Langner; Shahram Mirzazade; Martin Kronenbuerger; Cornelius Werner; N Jon Shah; Jörg B Schulz; Simon B Eickhoff; Kathrin Reetz
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

5.  The impact of different types of assistive devices on gait measures and safety in Huntington's disease.

Authors:  Anne D Kloos; Deborah A Kegelmeyer; Susan E White; Sandra K Kostyk
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.

Authors:  Jessica Despard; Anne-Marie Ternes; Bleydy Dimech-Betancourt; Govinda Poudel; Andrew Churchyard; Nellie Georgiou-Karistianis
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

7.  The Effects of Repeat Testing, Malingering, and Traumatic Brain Injury on Computerized Measures of Visuospatial Memory Span.

Authors:  David L Woods; John M Wyma; Timothy J Herron; E W Yund
Journal:  Front Hum Neurosci       Date:  2016-01-05       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.